Although NR4A1 has been linked to the pathogenesis of fatty liver disease7 and hepatitis,49 this is the first evidence to uncover the pathogenic role exerted by NR4A1 in ARLD, and it may offer a novel insight into treatment for ARLD. The gene discussed is NR4A1; the disease is Hepatitis.